PhenoTech logo — Pioneering the future of hematology with innovative diagnost...

PhenoTech

Pioneering the future of hematology with innovative diagnostic and therapeutic solutions for optimal patient care.

Founded 2003 Seed Biotechnology, Health Care +1

General Information

Company Name PhenoTech
Founded Year 2003
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Seed
Social

Get notified when PhenoTech moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About PhenoTech

PhenoTech is a biotechnology startup founded in 2003 and is making waves in the health care and pharmaceutical industries. The company's slogan, "Pioneering the future of hematology with innovative diagnostic and therapeutic solutions for optimal patient care," reflects its commitment to revolutionizing the field. The company specializes in the discovery, development, and commercialization of diagnostic reagents for blood banks, providing Nanoscale Emissive Antibody-complexes for pre-transfusion testing as well as therapeutic agents, including human-like monoclonal antibodies for treating Idiopathic Thrombocytopenic Purpura. Moreover, PhenoTech supplies anti-platelet agents like Infusable gpIIb/IIIa antagonists, crucial for patients undergoing certain cardiac procedures to prevent ischemic complications. The company recently secured a Seed Round investment on March 19, 2004, with BioAdvance as the lead investor. This injection of capital will undoubtedly fuel their pioneering work in hematology and further solidify their position as a leader in innovative diagnostic and therapeutic solutions for optimal patient care.

Taxonomy: diagnostic reagents, hematology, therapeutic solutions, blood banks, monoclonal antibodies, autoimmune disorder, Idiopathic Thrombocytopenic Purpura, anti-platelet agents, cardiac ischemic complications, Nanoscale Emissive Antibody-complexes, blood diagnostic, clinical testing, medical reagents

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
19 Mar 2004

PhenoTech Alternatives & Competitors

PhenoTech vs

Advancing molecular diagnostics to enhance detection of genetic, tumor, and infectious diseases.

Series B
Health Care
PhenoTech vs

Providing biological reagents, diagnostic kits, clinical trials, and comprehensive laboratory testin...

29 employees
Biotechnology
PhenoTech vs

Experience convenient at-home blood testing with advanced DNA-driven assays and cloud-based analytic...

Series Unknown
Health Care, Medical Devices

FAQ About PhenoTech

Pioneering the future of hematology with innovative diagnostic and therapeutic solutions for optimal patient care.
PhenoTech was founded in 2003.
PhenoTech operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
PhenoTech has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to PhenoTech include Pioneer Gene, International Point of Care Inc. | Fortis Life Sciences, InnaMed, NovAb, Caprico Biotechnologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PhenoTech and Pioneer Gene are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors PhenoTech and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy